MedPath

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

Phase 2
Completed
Conditions
Esophageal Cancer
Gastric Cancer
Registration Number
NCT00003237
Lead Sponsor
Eastern Cooperative Oncology Group
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug, and giving them after surgery, may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy, consisting of paclitaxel and cisplatin, given after surgery in treating patients with cancer of the esophagus or stomach.

Detailed Description

OBJECTIVES: I. Evaluate the disease free survival and overall survival of patients with adenocarcinoma of the esophagus, gastroesophageal junction, or cardia receiving post-operative adjuvant paclitaxel plus cisplatin.

OUTLINE: Patients undergo esophagogastrectomies within 4-12 weeks prior to the study. Patients receive intravenous paclitaxel over 3 hours on day 1, followed by intravenous cisplatin. Treatment is repeated every 21 days for 4 courses. Patients exhibiting disease recurrence or unacceptable toxic effects are removed from the study. Patients are followed every 3 months for 2 years, every 6 months for the next 3 years, and then every 12 months thereafter.

PROJECTED ACCRUAL: A total of 55 patients will be accrued within 16 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
55
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (30)

Robert H. Lurie Comprehensive Cancer Center, Northwestern University

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Veterans Affairs Medical Center - Chicago (Lakeside)

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

CCOP - Evanston

πŸ‡ΊπŸ‡Έ

Evanston, Illinois, United States

CCOP - Illinois Oncology Research Association

πŸ‡ΊπŸ‡Έ

Peoria, Illinois, United States

CCOP - Central Illinois

πŸ‡ΊπŸ‡Έ

Springfield, Illinois, United States

CCOP - Carle Cancer Center

πŸ‡ΊπŸ‡Έ

Urbana, Illinois, United States

CCOP - Cedar Rapids Oncology Project

πŸ‡ΊπŸ‡Έ

Cedar Rapids, Iowa, United States

CCOP - Ochsner

πŸ‡ΊπŸ‡Έ

New Orleans, Louisiana, United States

New England Medical Center Hospital

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Scroll for more (20 remaining)
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
πŸ‡ΊπŸ‡ΈChicago, Illinois, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.